产前短期地塞米松治疗期间 "妊娠区蛋白 "的血清水平

IF 3.5 2区医学 Q1 OBSTETRICS & GYNECOLOGY Acta Obstetricia et Gynecologica Scandinavica Pub Date : 2024-09-12 DOI:10.1111/j.1600-0412.1981.tb00030.x

B. Teisner, A. P. Lange, J. Folkersen, H. Anthonsen, B. von Schoultz, T. Stigbrand

{"title":"产前短期地塞米松治疗期间 \"妊娠区蛋白 \"的血清水平","authors":"B. Teisner, A. P. Lange, J. Folkersen, H. Anthonsen, B. von Schoultz, T. Stigbrand","doi":"10.1111/j.1600-0412.1981.tb00030.x","DOIUrl":null,"url":null,"abstract":"The serum concentration of the “Pregnancy Zone Protein” (PZP) was followed in 5 patients treated with dexamethasone (12 mg per day for 1 week) in the third trimester of pregnancy. The serum concentration of PZP was found to decrease significantly to an average of 58 per cent of the pretreatment levels.The simultaneous change in serum estriol levels during treatment and other factors of possible importance for the serum concentration of PZP are discussed.","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"13 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SERUM LEVELS OF THE “PREGNANCY–ZONE PROTEIN” DURING SHORT‐TERM PRENATAL DEXAMETHASONE THERAPY\",\"authors\":\"B. Teisner, A. P. Lange, J. Folkersen, H. Anthonsen, B. von Schoultz, T. Stigbrand\",\"doi\":\"10.1111/j.1600-0412.1981.tb00030.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The serum concentration of the “Pregnancy Zone Protein” (PZP) was followed in 5 patients treated with dexamethasone (12 mg per day for 1 week) in the third trimester of pregnancy. The serum concentration of PZP was found to decrease significantly to an average of 58 per cent of the pretreatment levels.The simultaneous change in serum estriol levels during treatment and other factors of possible importance for the serum concentration of PZP are discussed.\",\"PeriodicalId\":6990,\"journal\":{\"name\":\"Acta Obstetricia et Gynecologica Scandinavica\",\"volume\":\"13 1\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Obstetricia et Gynecologica Scandinavica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/j.1600-0412.1981.tb00030.x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Obstetricia et Gynecologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/j.1600-0412.1981.tb00030.x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

研究人员对 5 名妊娠三个月内接受地塞米松治疗（每天 12 毫克，持续一周）的患者的血清中 "妊娠带蛋白"（PZP）浓度进行了跟踪调查。研究还讨论了治疗过程中血清雌三醇水平的同步变化以及其他可能对 PZP 血清浓度有重要影响的因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

SERUM LEVELS OF THE “PREGNANCY–ZONE PROTEIN” DURING SHORT‐TERM PRENATAL DEXAMETHASONE THERAPY

The serum concentration of the “Pregnancy Zone Protein” (PZP) was followed in 5 patients treated with dexamethasone (12 mg per day for 1 week) in the third trimester of pregnancy. The serum concentration of PZP was found to decrease significantly to an average of 58 per cent of the pretreatment levels.The simultaneous change in serum estriol levels during treatment and other factors of possible importance for the serum concentration of PZP are discussed.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta Obstetricia et Gynecologica Scandinavica 医学-妇产科学

CiteScore

8.00

自引率

4.70%

发文量

180

审稿时长

3-6 weeks

期刊介绍： Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international journal dedicated to providing the very latest information on the results of both clinical, basic and translational research work related to all aspects of women’s health from around the globe. The journal regularly publishes commentaries, reviews, and original articles on a wide variety of topics including: gynecology, pregnancy, birth, female urology, gynecologic oncology, fertility and reproductive biology.